Piu Medical Valuation Multiples

Piu Medical is valued at $41M as of October 2026, a 0.7x revenue multiple. In the last 12 months, Piu Medical revenue was $55M and Piu Medical EBITDA was $5M.

Piu Medical Overview

About Piu Medical

Piu Medical is an Italian pharmacy consolidation platform that follows a buy, fix and scale model and is based in Castronno, in the province of Varese. The group develops and manages pharmacies and integrated healthcare services in Northern Italy, with a strong footprint in Lombardy. It managed 16 pharmacies at the end of 2025 and generated about EUR 27 million of revenue. The company listed on Euronext Growth Milan in November 2025, raising EUR 13.3 million at a market capitalisation of EUR 38.1 million. In December 2025 the IPO Club 2 fund managed by Azimut with Electa Ventures invested EUR 5 million through a reserved capital increase. Its first acquisition after the listing was Farmacia Formaggia in Milan, completed in July 2026, and in August 2026 it agreed to buy 60% of Farmacia dell'Aquila in Genoa.


Founded

N/A

HQ

Italy

Employees

N/A

Sectors

Financials (LTM)

Revenue: $55M
EBITDA: $5M

EV

$38M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Piu Medical Financials

Piu Medical reported last 12-month revenue of $55M and EBITDA of $5M.

In the same LTM period, Piu Medical generated $20M in gross profit, $5M in EBITDA, and $1M in net income.


Piu Medical P&L

In the most recent fiscal year, Piu Medical reported revenue of $29M and EBITDA of $4M.

Piu Medical is profitable as of last fiscal year, with gross margin of 36%, EBITDA margin of 12%, and net margin of 5%.

See analyst estimates for Piu Medical
LTMLast FY20242025202620272028
Revenue$55M$29M$29M$31M
Gross Profit$20M$11M$11M$12M
Gross Margin37%36%36%37%
EBITDA$5M$4M$4M$4M
EBITDA Margin9%12%12%12%
EBIT Margin6%10%10%8%
Net Profit$1M$1M$1M$944K
Net Margin3%5%5%3%
Net Debt-$11M--

Financial data powered by Morningstar, Inc.

Piu Medical Stock Performance

Piu Medical has current market cap of $41M, and enterprise value of $38M.

Market Cap Evolution


Piu Medical's stock price is $5.73.

Piu Medical has an EPS (earnings per share) of $0.20.

See more trading valuation data for Piu Medical
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$38M$41M-4.7%---$0.20

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Piu Medical Valuation Multiples

Piu Medical trades at 0.7x EV/Revenue multiple, and 7.5x EV/EBITDA.

See NTM and 2027E valuation multiples for Piu Medical

Piu Medical Financial Valuation Multiples

As of October 22, 2026, Piu Medical has market cap of $41M and EV of $38M.

Piu Medical has a P/E ratio of 29.3x.

LTMLast FY20242025202620272028
EV/Revenue0.7x1.3x1.3x1.2x
EV/EBITDA7.5x10.8x10.8x10.5x
EV/EBIT11.0x13.5x13.5x14.5x
EV/Gross Profit1.9x3.6x3.6x3.3x
P/E29.3x29.2x29.2x43.6x
EV/FCF(44.6x)--32.6x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Piu Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Piu Medical Margins & Growth Rates

Piu Medical grew revenue by 7% and EBITDA by 2% in the last fiscal year.

In the most recent fiscal year, Piu Medical reported gross margin of 36%, EBITDA margin of 12%, and net margin of 5%.

See estimated margins and future growth rates for Piu Medical

Piu Medical Margins

Last FY202420252026202720282029
Gross Margin36%36%37%37%
EBITDA Margin12%12%12%9%
EBIT Margin10%10%8%6%
Net Margin5%5%3%2%
FCF Margin--4%(2%)

Piu Medical Growth Rates

FY+1/FY24/2525/2626/2727/2828/29
Revenue Growth7%7%95%
Gross Profit Growth9%9%94%
EBITDA Growth2%2%50%
EBIT Growth(7%)(7%)39%
Net Profit Growth(33%)(33%)60%
FCF Growth--(214%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Piu Medical Operational KPIs

Piu Medical's Rule of 40 is 104% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Piu Medical's Rule of X is 248% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Piu Medical
LTMLast FY2024202620272028
Rule of 4026%104%-
Bessemer Rule of X52%248%-
S&M Expenses to Revenue-0%0%
G&A Expenses to Revenue-0%0%
Opex to Revenue-27%27%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Piu Medical Competitors

Piu Medical competitors include Meds Apotek, MedPal AI, PetMeds, BlueMTec, SC Ropharma, Farmacosmo, d1000, Rise, MARX Biotech and Wellgistics Health.

Most Piu Medical public comparables operate across Pharmacies.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Meds Apotek$102M$2M0.4x0.3x20.5x8.8x
MedPal AI-($5M)--(10.6x)-
PetMeds$179M($48M)0.1x0.1x(0.3x)-
BlueMTec$140M$540K0.6x-146.1x-
SC Ropharma$251M$12M0.1x-2.0x-
Farmacosmo$62M$371K0.4x-65.8x-
d1000$531M$42M0.3x0.4x3.9x9.3x
Rise$3M$879K4.5x4.5x14.0x-

This data is available for Pro users. Sign up to see all Piu Medical competitors and their valuation data.

Start Free Trial

Piu Medical VC Funding History

Before going public, Piu Medical raised $6M in total equity funding, across 1 round.


Piu Medical Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Dec-25Undisclosed stageIPO Club 2$6M-The IPO Club 2 fund, managed by Azimut Investments with Electa Ventures as partner and strategic advisor, invested EUR 5 million in Piu Medical on 29 December 2025 through a private investment in public equity. A term sheet had been signed on 10 December 2025. IPO Club 2 set up a 42-month vehicle, IPOC 9 S.r.l., which subscribed 833,333 newly issued ordinary shares at EUR 6.00 per share, in line with the November 2025 IPO price, for EUR 4,999,998 in cash. The shares came from the tranche of the capital increase approved on 13 November 2025 that was not placed in the IPO. The founder G.S.M. S.r.l. contributed 700,000 Piu Medical shares to IPOC 9, which is owned 54.35% by IPO Club 2 and 45.65% by the founders. After the transaction IPOC 9 held 20.35% of the share capital and 14.35% of the voting rights, and shareholders committed to hold their shares for 36 months. The proceeds support the business plan and finance external growth in retail pharmacy. Piu Medical is a pharmacy consolidation platform that managed 16 pharmacies at the end of 2025.

Acquisitions by Piu Medical

Piu Medical has acquired 1 company to date.

Last acquisition by Piu Medical was on July 2nd 2026. Piu Medical acquired Farmacia Formaggia for $15M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Piu Medical

Farmacia Formaggia
Description
Farmacia Formaggia is a premium-positioned pharmacy on Corso Buenos Aires in Milan, a main commercial thoroughfare with high local and passing foot traffic. It combines traditional pharmacy services with higher value services, including aesthetic medicine, telemedicine diagnostics, teledermatology, galenic preparations and medical equipment rental. It also holds a wholesale distribution authorisation that lets it supply other pharmacies and act as a purchasing hub. The pharmacy reported revenues of about EUR 7.7 million and EBITDA of about EUR 1.2 million for 2025, an EBITDA margin of about 15%, under Italian accounting standards. Its founder, Dr. Antonietta Travierso, continued to work with the buyer after the sale. Before the sale the business was converted into a limited liability company.
HQ CountryItaly
HQ City
Milan
Deal Date2 Jul 2026
Valuation$15M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Piu Medical acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Piu Medical

Where is Piu Medical headquartered?Piu Medical is headquartered in Italy.
Is Piu Medical publicly listed?Yes, Piu Medical is a public company listed on Borsa Italiana.
What is the stock symbol of Piu Medical?Piu Medical trades under PMED ticker.
When did Piu Medical go public?Piu Medical went public in 2025.
Who are competitors of Piu Medical?Piu Medical main competitors include Meds Apotek, MedPal AI, PetMeds, BlueMTec, SC Ropharma, Farmacosmo, d1000, Rise, MARX Biotech, Wellgistics Health.
What is the current market cap of Piu Medical?Piu Medical's current market cap is $41M.
What is the current revenue of Piu Medical?Piu Medical's last 12 months revenue is $55M.
What is the current revenue growth of Piu Medical?Piu Medical revenue growth (NTM/LTM) is 17%.
What is the current EV/Revenue multiple of Piu Medical?Current revenue multiple of Piu Medical is 0.7x.
What is the current EBITDA of Piu Medical?Piu Medical's last 12 months EBITDA is $5M.
What is Piu Medical's EBITDA margin?Piu Medical's last 12 months EBITDA margin is 9%.
What is the current EV/EBITDA multiple of Piu Medical?Current EBITDA multiple of Piu Medical is 7.5x.
What is the current FCF of Piu Medical?Piu Medical's last 12 months FCF is ($862K).
What is Piu Medical's FCF margin?Piu Medical's last 12 months FCF margin is (2%).
What is the current EV/FCF multiple of Piu Medical?Current FCF multiple of Piu Medical is (44.6x).
How many companies Piu Medical has acquired to date?As of October 2026, Piu Medical has acquired 1 company.
What was the largest acquisition by Piu Medical?$15M acquisition of Farmacia Formaggia on 2nd July 2026 was the largest M&A Piu Medical has done to date.
What companies Piu Medical acquired?Piu Medical acquired Farmacia Formaggia.
In how many companies Piu Medical has invested to date?Piu Medical hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Piu Medical

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial